| 常用名 | Omigapil maleate | CAS号 | 200189-97-5 |
|---|---|---|---|
| 价格 | ¥5960.0/50mg ¥需询单/1g ¥需询单/1g ¥需询单/1g | 纯度 | 99.0% |
| 备货期 | 1天 | 库存 | 现货 |
| 产品网页 | http://www.aladdin-e.com/zh_cn/C288106.html | ||
| 产品详情(用途,包装等)
用途: Omigapil maleate is a drug that was developed by Novartis and tested in clinical trials for its ability to help treat Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS). The development for PD and ALS have been terminated due to lack of benefit, but Santhera Pharmaceuticals bought the compound for development for the treatment of congenital muscular dystrophy (CMD). 物理化学性质: CAS号:200189-97-5 常用中文名:Omigapil maleate 常用英文名:CGP 3466B maleate 分子式:C23H21NO5 分子量:391.41700 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A 储存条件:-20°C,密闭,干燥 |